|
1
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163.
2005.PubMed/NCBI
|
|
2
|
Wesche-Soldato DE, Swan RZ, Chung CS and
Ayala A: The apoptotic pathway as a therapeutic target in sepsis.
Curr Drug Targets. 8:493–500. 2007. View Article : Google Scholar
|
|
3
|
Earnshaw WC, Martins LM and Kaufmann SH:
Mammalian caspases: structure, activation, substrates, and
functions during apoptosis. Annu Rev Biochem. 6:383–424. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stennicke HR and Salvesen GS: Properties
of the caspases. Biochim Biophys Acta. 1387:17–31. 1998. View Article : Google Scholar
|
|
5
|
Makin G and Dive C: Apoptosis and cancer
chemotherapy. Trends Cell Biol. 11:S22–S26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hart IR, Goode NT and Wilson RE: Molecular
aspects of the metastatic cascade. Biochem Biophys Acta. 989:65–84.
1989.PubMed/NCBI
|
|
8
|
Jiang WG, Puntis MCA and Hallet MB: The
molecular and cellular basis of cancer invasion and metastasis and
its implications for treatment. Br J Surg. 81:1576–1590. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martin TA and Jiang WG: Loss of tight
junction barrier function and its role in cancer metastasis.
Biochim Biophys Acta. 1788:872–891. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duffy MI, Maguire TM, Hill A, McDermott E
and O’Higgins N: Metalloproteinases: role in breast carcinogenesis,
invasion and metastasis. Breast Cancer Res. 2:252–257. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vihinen P, Ala-aho R and Kähäri VM: Matrix
metalloproteinases as therapeutic targets in cancer. Curr Cancer
Drug Targets. 5:203–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gibbs DF, Warner RL, Weiss SJ, Johnson KJ
and Varani J: Characterization of matrix metalloproteinases
produced by rat alveolar macrophages. Am J Respir Cell Mol Biol.
20:1136–1144. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cockett MI, Murphy G, Birch ML, O’Connell
JP, Crabbe T, Millican AT, Hart IR and Docherty AJ: Matrix
metalloproteinases and metastatic cancer. Biochem Soc Symp.
63:295–313. 1998.PubMed/NCBI
|
|
14
|
Matrisian LM: The matrix-degrading
metalloproteinases. Bioessays. 14:455–463. 1992. View Article : Google Scholar
|
|
15
|
Uzui H, Harpf A, Liu M, Doherty TM, Shukla
A and Chai N: Increased expression of membrane type 3-matrix
metalloproteinase in human atherosclerotic plaque: role of
activated macrophages and inflammatory cytokines. Circulation.
106:3024–3030. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lambert E, Dasse E, Haye B and Petitfrere
E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol.
49:187–198. 2004. View Article : Google Scholar
|
|
17
|
Chen KK and Kovarikova A: Pharmacology and
toxicology of toad venom. J Pharm Sci. 56:1535–1541. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clarke BT: The natural history of
amphibian skin secretions, their normal functioning and potential
medical applications. Biol Rev. 72:365–379. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Steyn PS and van Heerden FR:
Bufadienolides of plants and animal origin. Nat Prod Rep.
15:397–413. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nogawa T, Kamano Y, Yamashita A and Pettit
GR: Isolation and structure of five new cancer cell growth
inhibitory bufadienolides from the Chinese traditional drug Ch’an
Su. J Nat Prod. 64:1148–1152. 2001.PubMed/NCBI
|
|
21
|
Bhuiyan MB, Fant ME and Dasgupta A: Study
on mechanism of action of Chinese medicine Chan Su: dose-dependent
biphasic production of nitric oxide in trophoblastic BeWo cells.
Clin Chim Acta. 330:179–184. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ye M and Guo DA: Analysis of
bufadienolides in the Chinese drug Chan Su by high-performance
liquid chromatography with atmospheric pressure chemical ionization
tandem mass spectrometry. Rapid Commun Mass Spectrom. 19:1881–1892.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang SW, Lin H and Tsai SC: Effects of
methanol extract of Chansu on hypothalamic-pituitary-testis
function in rats. Metabolism. 47:1211–1216. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watabe M, Kawazoe N, Masuda Y, Nakajo S
and Nakaya K: Bcl-2 protein inhibits bufalin-induced apoptosis
through inhibition of mitogen-activated protein kinase activation
in human leukemia U937 cells. Cancer Res. 57:3097–3100. 1997.
|
|
25
|
Kawazoe N, Watabe M, Masuda Y, Nakajo S
and Nakaya K: Tiam1 is involved in the regulation of
bufalin-induced apoptosis in human leukemia cells. Oncogene.
18:2413–2421. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giri B and Gomes A, Debnath A, Saha A,
Biswas AK, Dasgupta SC and Gomes A: Antiproliferative, cytotoxic
and apoptogenic activity of Indian toad (Bufo melanostictus,
Schneider) skin extract on U937 and K562 cells. Toxicon.
48:388–400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang C, Chen A, Guo M and Yu J: Membrane
dielectric responses of bufalin-induced apoptosis in HL-60 cells
detected by an electrorotation chip. Biotechnol Lett. 29:1307–1313.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng
Y, Zhang J and Liu Y: PI3K/Akt is involved in bufalin-induced
apoptosis in gastric cancer cells. Anticancer Drugs. 20:59–64.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ko WS, Park TY, Park C, Kim YH, Yoon HJ,
Lee SY, Hong SH, Choi BT, Lee YT and Choi YH: Induction of
apoptosis by Chan Su, a traditional Chinese medicine, in human
bladder carcinoma T24 cells. Oncol Rep. 14:475–480. 2005.PubMed/NCBI
|
|
30
|
Yun HR, Yoo HS, Shin DY, Hong SH, Kim JH,
Cho CK and Choi YH: Apoptosis induction of human lung carcinoma
cells by Chan Su (Venenum bufonis) through activation of
caspases. J Acupunct Meridian Stud. 2:210–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ryu DS, Baek GO, Kim EY, Kim KH and Lee
DS: Effects of polysaccharides derived from Orostachys japonicus on
induction of cell cycle arrest and apoptotic cell death in human
colon cancer cells. BMB Rep. 43:750–755. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yue T, Yin J, Li F, Li D and Du M: High
glucose induces differentiation and adipogenesis in porcine muscle
satellite cells via mTOR. BMB Rep. 43:140–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho SY, Lee JH, Bae HD, Jeong EM, Jang GY,
Kim CW, Shin DM, Jeon JH and Kim IG: Transglutaminase 2 inhibits
apoptosis induced by calcium-overload through down-regulation of
Bax. Exp Mol Med. 42:639–650. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lazebnik YA, Kaufmann SH, Desnoyers S,
Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase
by a proteinase with properties like ICE. Nature. 371:346–347.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fukuda K: Apoptosis-associated cleavage of
β-catenin in human colon cancer and rat hepatoma cells. Int J
Biochem Cell Biol. 31:519–529. 1999.
|
|
36
|
De Graaf AO, De Witte T and Jansen JH:
Inhibitor of apoptosis proteins: new therapeutic targets in
hematological cancer? Leukemia. 18:1751–1759. 2004.PubMed/NCBI
|
|
37
|
Jing Y, Watabe M, Hashimoto S, Nakajo S
and Nakaya K: Cell cycle arrest and protein kinase modulating
effect of bufalin on human leukemia ML1 cells. Anticancer Res.
14:1193–1198. 1994.PubMed/NCBI
|
|
38
|
Nasu K, Nishida M, Ueda T, Takai N, Bing
S, Narahara H and Miyakawa I: Bufalin induces apoptosis and the
G0/G1 cell cycle arrest of endometriotic stromal cells: a promising
agent for the treatment of endometriosis. Mol Hum Reprod.
11:817–823. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takai N, Ueda T, Nishida M, Nasu K and
Narahara H: Bufalin induces growth inhibition, cell cycle arrest
and apoptosis in human endometrial and ovarian cancer cells. Int J
Mol Med. 21:637–643. 2008.PubMed/NCBI
|
|
40
|
Choi JH, Choi AY, Yoon H, Choe W, Yoon KS,
Ha J, Yeo EJ and Kang I: Baicalein protects HT22 murine hippocampal
neuronal cells against endoplasmic reticulum stress-induced
apoptosis through inhibition of reactive oxygen species production
and CHOP induction. Exp Mol Med. 42:811–822. 2010. View Article : Google Scholar
|
|
41
|
Murphy AN, Bredesen DE, Cortopassi G, Wang
E and Fiskum G: Bcl-2 potentiates the maximal calcium uptake
capacity of neural cell mitochondria. Proc Natl Acad Sci USA.
93:9893–9898. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Thees S, Hubbard GB, Winckler J, Schultz C
and Rami A: Specific alteration of the Bax/Bcl2 ratio and
cytochrome c without execution of apoptosis in the hippocampus of
aged baboons. Restor Neurol Neurosci. 23:1–9. 2005.PubMed/NCBI
|
|
43
|
Eckelman BP, Salvesen GS and Scott FL:
Human inhibitor of apoptosis proteins: why XIAP is the black sheep
of the family. EMBO Rep. 7:988–994. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hunter AM, LaCasse EC and Korneluk RG: The
inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis.
12:1543–1568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Galluzzi L, Larochette N, Zamzami N and
Kroemer G: Mitochondria as therapeutic targets for cancer
chemotherapy. Oncogene. 25:4812–4830. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gupta S, Kass GE, Szegezdi E and Joseph B:
The mitochondrial death pathway: a promising therapeutic target in
diseases. J Cell Mol Med. 13:1004–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Javadov S and Karmazyn M: Mitochondrial
permeability transition pore opening as an endpoint to initiate
cell death and as a putative target for cardioprotection. Cell
Physiol Biochem. 20:1–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mook OR, Frederiks WM and van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
49
|
Hazgui S, Bonnomet A, Nawrocki-Raby B,
Milliot M, Terryn C, Cutrona J, Polette M, Birembaut P and Zahm JM:
Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior
of tumor bronchial epithelial cells. Respir Res. 9:332008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Takada Y, Andreeff MM and Aggarwal BB:
Indole-3-carbinol suppresses NF-κB and IκBα kinase activation,
causing inhibition of expression of NF-κB-regulated antiapoptotic
and metastatic gene products and enhancement of apoptosis in
myeloid and leukemia cells. Blood. 106:641–649. 2005.
|
|
51
|
Choi YH, Choi WY, Hong SH, Kim SO, Kim GY,
Lee WH and Yoo YH: Anti-invasive activity of sanguinarine through
modulation of tight junctions and matrix metalloproteinase
activities in MDA-MB-231 human breast carcinoma cells. Chem Biol
Interact. 179:185–191. 2009. View Article : Google Scholar
|
|
52
|
Moon DO, Choi YH, Moon SK, Kim WJ and Kim
GY: Butein suppresses the expression of nuclear factor-κB-mediated
matrix metalloproteinase-9 and vascular endothelial growth factor
in prostate cancer cells. Toxicol In Vitro. 24:1927–1934. 2010.
|
|
53
|
Shin DY, Ryu CH, Lee WS, Kim DC, Kim SH,
Hah YS, Lee SJ, Shin SC, Kang HS and Choi YH: Induction of
apoptosis and inhibition of invasion in human hepatoma cells by
anthocyanins from meoru. Ann NY Acad Sci. 1171:137–148. 2009.
View Article : Google Scholar : PubMed/NCBI
|
